Prevention of primary tumor growth and suppression of metastasis with continuous, low-dose treatment with the angiogenic inhibitor, NORLEUAL, in a mouse model of breast cancer.

被引：0
|
作者：
Masino, JA [1 ]
Yamamoto, B [1 ]
Zornes, P [1 ]
Harding, JW [1 ]
机构：
[1] Washington State Univ, Pullman, WA 99164 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2003年 / 12卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1288S / 1289S
页数：2
相关论文
共 50 条
  • [1] Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model
    Lin, Kai-Ti
    Sun, Shu-Pin
    Wu, Jui-I
    Wang, Lu-Hai
    PLOS ONE, 2017, 12 (06):
  • [2] Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
    Wu, K
    Brown, P
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (11): : 766 - 767
  • [3] Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer
    Yao, M
    Zhou, W
    Sangha, S
    Albert, A
    Chang, AJ
    Liu, TC
    Wolfe, MM
    CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1618 - 1628
  • [4] Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy
    Munoz, R
    Shaked, Y
    Bertolini, F
    Emmenegger, U
    Man, S
    Kerbel, RS
    BREAST, 2005, 14 (06): : 466 - 479
  • [5] Low-dose celecoxib treatment modestly reduces tumor growth and incidence in the TRAMP model of prostate cancer
    Klein, RD
    Colby, JK
    Yang, P
    Newman, RA
    Fischer, SM
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1326S - 1326S
  • [6] ENDOCRINE EFFECTS OF LOW-DOSE AMINOGLUTETHIMIDE AS AN AROMATASE INHIBITOR IN THE TREATMENT OF BREAST-CANCER
    STUARTHARRIS, R
    DOWSETT, M
    DSOUZA, A
    DONALDSON, A
    HARRIS, AL
    JEFFCOATE, SL
    SMITH, IE
    CLINICAL ENDOCRINOLOGY, 1985, 22 (02) : 219 - 226
  • [7] IMMUNOLOGICAL MECHANISM OF THE LOW-DOSE RADIATION-INDUCED SUPPRESSION OF CANCER METASTASES IN A MOUSE MODEL
    Nowosielska, Ewa M.
    Cheda, Aneta
    Wrembel-Wargocka, Jolanta
    Janiak, Marek K.
    DOSE-RESPONSE, 2010, 8 (02): : 209 - 226
  • [8] Prevention of tumor growth and tumor-induced osteolysis by the RANKL inhibitor osteoprotegerin (OPG) is associated with significant improvement in survival using a mouse model of breast cancer bone metastasis
    Canon, J.
    Roudier, M.
    Bryant, R.
    Radinsky, R.
    Dougall, W.
    BONE, 2007, 40 (06) : S145 - S145
  • [9] Melatonin decreases metastasis, primary tumor growth and angiogenesis in a mice model of breast cancer
    Karadas, Asiye Kubra
    Dilmac, Sayra
    Aytac, Gunes
    Tanriover, Gamze
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2021, 40 (09) : 1545 - 1557
  • [10] Personalized tumor vaccine can suppress tumor growth and metastasis in the syngeneic mouse breast cancer model
    Moon, Hyeong-Gon
    Son, Hye Youn
    Heo, Woo Hang
    Quan, Mingji
    Li, Songbin
    Valentina, Haritonova
    Jeong, Hamin
    Han, Wonshik
    Lee, Han-Byoel
    Her, Yujeong
    CANCER RESEARCH, 2023, 83 (05)
12345